Wallach's Interpretation of Diagnostic Tests: Pathways to Arriving at a Clinical Diagnosis (1474 page)

Nontuberculous mycobacteria (NTM)

AFB, smear and culture

CF

pneumonia

TB

Nonulcerative dyspepsia

Norepinephrine.
See
Catecholamines

Normocytic anemia

erythropoietin

ferritin

iron

LPL/WM

MCV

radiation nephropathy

RDW

TIBC

Norovirus gastroenteritis (Norwalk Agent)

Norwalk agent

NPD.
See
Niemann-Pick disease (NPD)

NPV.
See
Negative predictive value (NPV)

NSAIDs

anti-inflammatory drugs, TDM

nonatrophic (type B gastritis)

NSCLC.
See
Non-small cell lung cancer (NSCLC)

NSE.
See
Neuron-specific enolase (NSE)

NSHL.
See
Nonsyndromic hearing loss and deafness (NSHL)

NSTEMI.
See
Non-ST segment elevation myocardial infarction (NSTEMI)

NTD.
See
Neural tube defects (NTD)

N
-terminal pro b-type natriuretic peptide.
See
Brain natriuretic peptide (BNP)

NTM.
See
Nontuberculous mycobacteria (NTM)

NT-proBNP.
See also
Brain natriuretic peptide (BNP)

congestive heart failure

heart failure

heart failure with preserved ejection fraction

ILCA

pericardial constriction

pulmonary embolism

O

Obstetric disorders

amniotic fluid embolism

chorioamnionitis

eclampsia

ectopic pregnancy

fetal death in utero

gestational trophoblastic disease

multiple gestations

placenta abruptio

placenta previa

postterm pregnancy

preeclampsia

preterm delivery

ruptured membranes

Occult blood, stool

diverticulosis, colon

gFOBT

GI bleeding

stomach carcinoma

syncope

OCPs.
See
Oral contraceptive pills (OCPs), galactorrhea

Oculomotor nerve palsy

OGTT.
See
Oral glucose tolerance test (OGTT)

OI.
See
Osteogenesis imperfecta (OI)

Oligoclonal IgG bands, multiple sclerosis

Oliguria, acute kidney injury

O&P examinations.
See
Ova and parasite examination, stool

Ophthalmoplegia

Opiates.
See also
Opioids

addiction medicine, drug testing panel

pain management, urine drug testing panel

Opioids

addiction medicine, drug testing panel

opiate screening assays

pain management, urine drug testing panel

pain treatment

Optic neuritis.
See
Retrobulbar neuropathy

Oral contraceptive pills (OCPs), galactorrhea

Oral glucose tolerance test (OGTT)

Organ specific autoimmune disease

Oriental sore, leishmaniasis

Osmolal gap

renal tubular acidosis

lactic acidosis

Osmolality

acute tubular necrosis

diabetes insipidus

hypercalcemic nephropathy

hypopituitarism

serum and urine

SIADH

stool

Osmolarity, hyperosmolar hyperglycemic nonketotic coma

Osmotic and mechanical fragility, clostridial gangrene

Osmotic diarrhea

Osmotic fragility

hereditary elliptocytosis

hereditary spherocytosis

Osteitis fibrosa cystica

Osteogenesis imperfecta (OI)

Osteoporosis

bone densitometry

hyperparathyroidism

prevalence

OVA1

epithelial ovarian carcinoma

ovarian carcinomas

Ova and parasite examination, stool

Ascaris lumbricoides

coccidia

Cryptosporidium
antigen detection

Cryptosporidium parvum

diarrhea

GI symptoms

Giardia
antigen detection test

giardiasis

hyperinfection syndrome

parasitic infection

pork tapeworm disease

protozoal infection

schistosomiasis

Taenia
infection

trichinosis

Ovarian cancer

epithelial carcinomas

OVA1

ovarian germ cell neoplasms

ovarian sex cord-stromal neoplasms

Ovarian germ cell neoplasms

AFP

gynecologic disorders

hCG

lactate dehydrogenase (LDH)

Ovarian sex cord-stromal neoplasms

AFP

androstenedione

BRCA1

clinical presentation

DICER1

estradiol

FOXL2

hCG

inhibin

lactate dehydrogenase (LDH)

müllerian inhibiting substance (MIS)

testosterone

Ovulatory disorders

dehydroepiandrosterone (DHEA-sulfate)

estradiol

FSH

gonadotropin-releasing hormone (GnRH)

hirsutism

2-hour glucose tolerance test

infertility

polycystic ovary syndrome (PCOS)

prolactin

T
⁴

testosterone

thyroid-stimulating hormone (TSH)

turner syndrome (XO)

XY females

Oxycodone, pain management

Oxy-morphone, pain management

P

PA.
See
Pernicious anemia (PA)

PAC.
See
Plasma aldosterone concentration (PAC)

PAI 1.
See
Plasminogen activator inhibitor 1 (PAI 1)

Pain management drugs

application

confirmation methods and limitations

drugs of abuse, TDM

quantitative results interpretation

screening methods and limitations

Pancreas disorders

cancer,
H. pylori
serology screen

carcinoma

amylase

bilirubin

CA 19–9

carcinoembryonic antigen (CEA)

cholesterol

endoscopic retrograde cholangiopancreatography (ERCP)

glucose tolerance

glycoprotein 2

lipase

prothrombin time (PT)

radioisotope scanning

serum ALP

serum LAP

cystic fibrosis

dyspepsia and peptic ulcer disease

macroamylasemia

pancreatitis

acute

chronic

pseudocyst

Pancreatic exocrine insufficiency

Pancreatitis

acute

amylase level

bilirubin, serum levels

calcium, serum level

CRP

laboratory criteria and findings

serum lipase

trypsin, serum levels

amylase

arterial pO
²

AST

autoimmune

bilirubin

blood glucose

BUN

calcium

chronic

cholecystokinin-secretin test

chronic pancreatitis

glucose tolerance test

imaging studies

pancreatic exocrine insufficiency

serum pancreolauryl test

xylose tolerance test

creatinine

CRP

glucose

hemoconcentration (Hct)

LD

lipase

metabolic acidosis

paO
²

trypsin

WBC

Pancreolauryl test

Pancytopenia disorder

aplastic anemias

etiology

FISH